Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
TARLATAMAB-DLLE 10MG INJ (CDM 717086306) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 4, 2026 , from http://ppman.hank.ai/transparency/procedure/717086306/by-state?code_type=CDM
“TARLATAMAB-DLLE 10MG INJ (CDM 717086306) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/717086306/by-state?code_type=CDM. Accessed
November 4, 2026 .
“TARLATAMAB-DLLE 10MG INJ (CDM 717086306) by State,” HANK Price Transparency ,
accessed November 4, 2026 ,
http://ppman.hank.ai/transparency/procedure/717086306/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
717086306 — Tarlatamab-dlle 10mg Inj
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$29,250
National median
$23,625 – $33,375
IQR (p25 – p75)
3
hospitals filing
1
states
Walking in without insurance?
Cash / self-pay price
Cash median
$22,500
vs. negotiated
-23.1%
Hospitals reporting
3
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 717086306 (CDM), with interquartile range
State Median p25 p75
IN $29,250 $23,625 $33,375